The ranibizumab Port Delivery System (PDS) for neovascular age-related macular degeneration (AMD) may involve more risk of adverse effects than monthly injections. Source: AAO
A large-scale investigation links age, race, ethnicity, and insurance status with failure to follow through with anti-VEGF therapy for neovascular age-related macular degeneration (AMD). Source: AAO
A small retrospective study suggests that repeating corneal crosslinking can be effective and well tolerated in patients with progressive keratoconus. Source: AAO
The absence of retinal fluid after anti-VEGF treatment for neovascular age-related macular degeneration (AMD) correlated with better outcomes in this 2-year post hoc study. Source: AAO
Coffee and tea consumption promotes retinal thickness, retinopathy of prematurity (ROP) rates in the US have been rising for years, and new AMD research focuses on genes. Source: AAO
A Danish investigation into the genetics behind uveal melanoma suggests a link between certain chromosomal alterations and earlier recurrence of tumors. Source: AAO
Investigators sought to determine whether intravitreal or oral steroids were more effective at postsurgical inflammation control in patients with uveitis. Source: AAO
A Brazilian retrospective review found baseline steeper maximum keratometry and a history of allergies were associated with faster keratoconus progression in pediatric patients. Source: AAO
Imaging can be used to identify cerebral malaria and its associated retinopathy, retinal vein occlusion (RVO) is a rare side effect of the COVID-19 vaccine, and ChatGPT finds board test prep questions difficult. Source: AAO
This study examined retinopathy of prematurity (ROP) re-treatment rates following initial ROP treatment with anti-VEGF therapy (ranibizumab or bevacizumab) at various doses. Source: AAO